When DECTRIS was founded in 2006, replacing traditional CCD detectors and film with Hybrid Photon Counting (HPC) pixel sensors seemed almost impossible. Today, DECTRIS technology powers groundbreaking research across synchrotrons, electron microscopes, and industrial laboratories worldwide, delivering instruments precise enough to reveal what was previously invisible.
To mark our 20th anniversary, our founder Christian Brönnimann sat down to reflect on the early risks, debugged cleanrooms, and technology breakthroughs that transformed a small academic spin-off into a trusted partner for cutting-edge research and innovation.
In the beginning, two-dimensional Hybrid Photon Counting (HPC) technology was just a visionary idea existing entirely in the minds of Christian Brönnimann and his small team at the Paul Scherrer Institute (PSI). The core objective was to count individual X-ray photons with zero detector noise, delivering the speed and sensitivity needed to reveal previously invisible structures and unlock new possibilities across scientific research. But translating a concept from a tiny piece of silicon into a camera big enough for complex science seemed almost impossible.
"At the beginning, this technology was just in our minds to do two-dimensional pixel sensors. I had prototypes which were the size of my fingernail. How could you come up with a camera for protein crystallography, which needs 40 by 40 square centimeters? It was kind of crazy to try to do it."
Building on their close ties with PSI's high-energy physics group, the team used an incubator setup to prove that their fingernail-sized prototypes could be scaled up. Operating under PSI’s umbrella gave the young startup two vital years of subsidized infrastructure. The true commercial turning point arrived unannounced in late 2007 when a team of American researchers from Stanford University visited their office after testing a PILATUS demonstrator unit at a beamline.
"They came to our office - and Americans like that 'garage' thing. Two weeks later, there was a regular letter with a check for 600,000 Swiss francs, which I had to carry to the bank myself. It was completely crazy, but things went so fast because the key opinion leaders could suddenly do experiments they couldn't do before. That changed everything."
Leaving PSI after two years meant stepping into the operational deep end. Moving into dedicated facilities in Baden required building cleanrooms from scratch and establishing mature, repeatable manufacturing processes for PILATUS2 - a transition that brought unexpected, high-stakes roadblocks.
"The big challenge was bringing the technology from the lab to a mature company state. All of a sudden, it didn't work anymore - we couldn't produce one good module. We had ESD problems, reflow didn't work, and we even contaminated the whole cleanroom because we were running in and out solving the problem. It took half a year to debug everything."
Once those manufacturing hurdles were cleared, things really took off. The PILATUS 2 product line was incredibly successful, with revenue peaking at 24MCH in 2010, just four years after its market entry. Winning the Swiss Economic Forum (SEF) Award for outstanding start-ups in 2010 was the proof thatthis success was not unnoticed.
With initial successes secured, the next question became: What’s next?
The answer was PILATUS3, a new product family that delivered a tenfold increase in performance. Representing the logical next step in the company's evolution, it was the first complete DECTRIS platform where all components were developed entirely in-house by our staff.
While PILATUS3 continued to drive phenomenal success at synchrotrons, it also increasingly made its mark in laboratory environments. At the same time, the company licensed the EIGER technology from PSI, keeping the engineering team relentlessly busy as they adapted the new detector to meet DECTRIS’ needs.
This rapid technological expansion required a growing, highly specialized workforce. DECTRIS soon outgrew its home base at Neuenhoferstrasse and was looking for a new location that could match its ambitions. In 2015, the team customized the entire layout of the new Täfernhof facility, installing a four-meter cleanroom ceiling, custom lifts, and standardized laboratory environments. More than just a change of address, this move cemented DECTRIS’ transition from an ambitious startup into an established small and medium-sized Enterprise (SME).
By this stage, DECTRIS X-ray detectors had become indispensable tools in structural biology, playing a critical role in developing life-saving medicines during global health crises and accelerating clean energy research.
As customer adoption grew, DECTRIS began expanding beyond its core X-ray heritage. In 2018, the company launched its first dedicated Electron Microscopy (EM) cameras, such as ELA and QUADRO, bringing HPC technology's speed and direct detection capabilities to electron microscopes and material imaging.
To support this growing global footprint, DECTRIS opened subsidiaries in the United States (2018) and Japan (2019), with local sales teams and around-the-clock technical support.
"Support people have the closest contact with customers. They know what their problems are, what experiments they do, whether they got new funding, and what their future plans are. Having a subsidiary in the same time zone as the customer was very important."
Throughout this global expansion, Christian maintained that the true engine of DECTRIS was never just the silicon sensors - it was the people building them.
"My goal was always to employ the best people - that’s actually the key. If you have such a highly qualified team, you're always able to attack a different problem. We always spent a lot of effort on our company culture."
Today, DECTRIS has entered its next era under CEO Matthias Schneebeli. Having redefined what is possible at synchrotrons and in laboratories worldwide, the company is applying its detection technology to new industries, like battery research and semiconductor diagnostics.
At the same time, DECTRIS is expanding from a hardware pioneer into an end-to-end partner for cutting-edge research and innovation. Through D.LAB, the company unifies lab data, tools, compute, and analytics into one collaborative platform - while also adapting its zero-noise technology for clinical Medical CT to drastically reduce radiation dosage and deliver sharper diagnostic images.
"We are looking into many new horizons and as an independent supplier of this technology, we have a very exciting role to play. All in all, I think we have a bright future ahead of us, and I'm convinced we're going to be successful."